As shown in Fig. 6g, h, treatment with ABT263 resulted in a marked reduction of the tumor growth rate of both HCT116 IDH1 WT- as well as HCT116 IDH1 R132H-expressing tumors. The gene discussed is IDH1; the disease is neoplasm.